CanSino Biologics Maximum Drawdown
| CASBF Stock | | | USD 3.86 0.00 0.00% |
The Maximum Drawdown signal for CanSino Biologics reflects patterns observed in trading data. Comparable indicator datasets are structured within
Equity Screeners. CanSino Biologics has a market cap of 3.15 B, operating margin of -19.33%, current ratio of 2.99. See
Trending Equities for additional portfolio context. Adding CanSino Biologics to a portfolio enables side-by-side comparison with other holdings. This enables performance tracking across the full position set. Broader economic conditions can influence CanSino Biologics's company valuation — related indicators include
signals in bureau of labor statistics.
CanSino Biologics has current Maximum Drawdown of 27.09. Maximum Drawdown (or MDD) is another indicator of risk. It is the reduction in asset value after a series of losing trades. This is normally calculated by getting the difference between a relative peaks in equity capital minus a relative trough.
Maximum Drawdown | = | MAX(HIGH - LOW) |
| = | 27.09 | |
| MAX | = | Maximum notation for the range of returns on CanSino Biologics |
Maximum Drawdown Peers Comparison
Maximum Drawdown Relative To Other Indicators
CanSino Biologics ranks
third among pink sheets in maximum drawdown across its competitive set. It is currently under evaluation in maximum drawdown across its competitive set at roughly
1.00 Maximum Drawdown per unit of Maximum Drawdown.
The MDD is one of the most important risk measures. It measures the loss in any losing period and is usually defined as the percent retrenchment from an asset peak value to the valley value. Maximum drawdown encompasses both the period from the peak to the valley (length), and the time from the valley to a new high (recovery). It measures the largest percentage drawdown that has occurred in a given time period.
Compare CanSino Biologics to Peers
Other Technical Indicators